Why an FDA advisory panel’s meeting on Covid-19 vaccines matters
This week’s meeting, while likely dry and technical, “shows the public that this is how FDA is going about its decisions,” one expert said.
This week’s meeting, while likely dry and technical, “shows the public that this is how FDA is going about its decisions,” one expert said.
A new Science paper from the Baker lab details a novel method for quickly compiling a large library of macrocycle drug candidates.
Cigna plans to make copies of AbbVie’s Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
Boston, Mass. STAT, the leading health and science news publication, and the Knight Science Journalism Program at the Massachusetts Institute of
STAT’s Casey Ross and Bob Herman have won the Batten Medal, one of the most prestigious awards in American journalism, for their “Denied by AI”…
Improving prior authorization requires shifting to a more collaborative framework focused on the medical evidence and what’s best for each patient.
As national awareness of mental illness rises and innovative care models emerge, many advocates now see a rare opportunity to remake mental health crisis care…
It’s a “Sputnik moment” for academical medical centers. Other countries are making large investments in medical research and infrastructure. The U.S. needs to do the…
Donald Trump’s health care priorities remain fuzzy. But one thing is certain: A second Trump administration would put its own stamp on a host of…
The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive amounts of vaccine.
Amid layoffs and a hit to earnings, Bristol’s new CEO shares his vision for the future.